|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|
| Operating Activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to cash provided from (used for) operations: | |||
| Depreciation and amortization | |||
| Goodwill, Impairment Loss | |||
| Deferred income taxes | |||
| Restructuring and other charges | |||
| Net periodic pension benefit cost | |||
| Stock-based compensation | |||
| Amortization of debt issuance costs | |||
| Other | |||
| Changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments: | |||
| Decrease (Increase) in receivables | |||
| (Increase) Decrease in inventories | |||
| (Increase) in prepaid expenses and other current assets | |||
| (Decrease) Increase in accounts payable, trade | |||
| Increase (Decrease) in accrued expenses | |||
| Increase in taxes, including income taxes | |||
| Pension contributions | |||
| (Increase) Decrease in noncurrent assets | |||
| Increase in noncurrent liabilities | |||
| Cash provided from (used for) operations | |||
| Financing Activities | |||
| Net transfers from former parent company | |||
| Debt issuance costs | |||
| Payments on debt (original maturities greater than three months) | |||
| Other | |||
| Cash (used for) provided from financing activities | |||
| Investing Activities | |||
| Capital expenditures | |||
| Proceeds from the sale of assets and businesses | |||
| Payments for (Proceeds from) Other Investing Activities | |||
| Cash used for investing activities | |||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||
| Net change in cash and cash equivalents and restricted cash | |||
| Cash and cash equivalents and restricted cash at beginning of year | |||
| Cash and cash equivalents and restricted cash at end of year | |||
| Payments for Repurchase of Common Stock |
Loading...
